Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01406405 · ClinicalTrials.gov registry record

PEEK and Allograft Spacers Evaluation in Spinal Fusion Surgeries

A clinical trial of Degenerative Disc Disease, sponsored by Justin Parker Neurological Institute.

Completed
Registry status
240
Enrollment target
1
Study location

NCT01406405: Completed study of Degenerative Disc Disease, sponsored by Justin Parker Neurological Institute.

NCT01406405 is a study of Degenerative Disc Disease that has completed, run by Justin Parker Neurological Institute. The registered enrollment target is 240 participants, above the 163-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (47% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01406405, a study of Degenerative Disc Disease, has completed, sponsored by Justin Parker Neurological Institute.

COMPLETED
Registry status
240 participants
Enrollment target
1
Study location

Study Summary

Purpose The primary purpose of this study is to prospectively compare clinical and radiographic clinical outcomes in patients undergoing cervical or lumbar interbody fusions and randomized to receive either polyetheretherketone (PEEK) or cortical allografts.

Primary Outcome

Improvement in the Neck/Arm or Low Back/Leg Visual Analog pain Scale (VAS) scores. A 30% reduction in pain intensity will be considered to be a successful response to treatment.

Conditions Studied

Interventions

  • PROCEDURE Posterior/Transforaminal Lumbar Interbody Fusion (P/TLIF), Anterior Cervical Discectomy and Fusion (ACDF)

Study Locations (1)

Colorado

  • Boulder Neurosurgical Associates - Boulder

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2011-07
Est. Completion 2018-05-16

What the finished NCT01406405 record still lists

NCT01406405 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, above the 163-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (47% higher).

The record links to 1 condition, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which Posterior/Transforaminal Lumbar Interbody Fusion (P/TLIF), Anterior Cervical Discectomy and Fusion (ACDF) is the first listed.

NCT01406405 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT01406405 about?

NCT01406405 is a clinical study titled "PEEK and Allograft Spacers Evaluation in Spinal Fusion Surgeries". Purpose The primary purpose of this study is to prospectively compare clinical and radiographic clinical outcomes in patients undergoing cervical or lumbar interbody fusions and randomized to receive either polyetheretherketone (PEEK) or cortical allografts.

What is the current status of trial NCT01406405?

This trial is currently completed. The enrollment target is 240 participants. The study started on 2011-07. Estimated completion is 2018-05-16.

What conditions does trial NCT01406405 study?

This clinical trial studies the following conditions: Degenerative Disc Disease.

What interventions are being tested in trial NCT01406405?

The interventions under investigation include: Posterior/Transforaminal Lumbar Interbody Fusion (P/TLIF), Anterior Cervical Discectomy and Fusion (ACDF) (PROCEDURE).

Who is sponsoring clinical trial NCT01406405?

This trial is sponsored by Justin Parker Neurological Institute, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01406405 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Degenerative Disc Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01406405's enrollment target sits among peer trials

240 9th of 42 higher than 34 of 42 other Degenerative Disc Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Degenerative Disc Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02855554 · 240 participants · NA

    Quantitative Cardiac Parametric Mapping

  • NCT03230565 · 240 participants · Phase 4

    Continuous Infusions vs Scheduled Bolus Infusions

  • NCT03399929 · 240 participants

    Traumatic Brain Injury and Stroke Long Term Outcome

  • NCT03583710 · 240 participants · Phase 3

    Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01406405, the US trial registry maintained by the National Library of Medicine. NCT01406405 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.